{
  "pmcid": "6939455",
  "sha256": "99a49f9159bd2774b17d52b337dc91b0f64604a0cf50a744a63c05394c896f9a",
  "timestamp_utc": "2025-11-09T22:52:36.588377+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.385761462882098,
    "reading_ease": 24.58554175764195,
    "word_count": 229
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Epiaortic Ultrasound in Surgical Aortic Valve Replacement"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "In a randomised controlled trial, SAVR patients were assigned to two embolic protection devices."
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 2,
        "evidence": "SAVR patients were assigned to two embolic protection devices."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Multivariable logistic regression estimated associations between atheroma grade and adverse outcomes, including death, stroke, cerebral infarction on DW-MRI, delirium, and acute kidney injury (AKI) by 7 and 30 days."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Of 383 randomised patients, 326 (85.1%) had pre-cannulation epiaortic ultrasound data."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Of 383 randomised patients, 326 (85.1%) had pre-cannulation epiaortic ultrasound data."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Moderate/severe atheroma grade was associated with a greater risk of AKI by 7 days (adjusted OR: 2.63; 95% CI: 1.24–5.58; p=0.01). At 30 days, these patients had a greater risk of death, stroke, or AKI (adjusted OR: 1.97; 95% CI: 1.04–3.71; p=0.04)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Moderate/severe atheroma grade was associated with a greater risk of AKI by 7 days (adjusted OR: 2.63; 95% CI: 1.24–5.58; p=0.01)."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 12,
    "max_score": 25
  }
}